Who
Robert Charles Peterson
Interim CEO
Company insider
Files Form 4 as: Interim CEO, Biote.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $290K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Feb 2024
- Last trade
- 12 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 16 Jun 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —206,746 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —206,746 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —107,169 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —107,169 at $0.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 9 Sep 2024filed 11 Sep 2024 | BTMD BiotePharmaceuticals | SEC FORM 4 Sold | $204K32,874 at $6.20 | filing |
| 9 Jul 2024filed 10 Jul 2024 | BTMD BiotePharmaceuticals | SEC FORM 4 Sold | $86K11,376 at $7.57 | filing |
| 8 Jul 2024filed 10 Jul 2024 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —44,250 at $0.00 | filing |
| 8 Jul 2024filed 10 Jul 2024 | BTMD BiotePharmaceuticals | SEC FORM 4 Code M | —44,250 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —44,250 at $0.00 | filing |
News
Clover Health Investments (NASDAQ:CLOV) vs. biote (NASDAQ:BTMD) Financial AnalysisBTMD · themarketsdaily.com · 15 Oct 2026Hims & Hers Health (NYSE:HIMS) vs. biote (NASDAQ:BTMD) Head-To-Head ContrastBTMD · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Robert Charles Peterson; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.